[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB8521705D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB8521705D0
GB8521705D0 GB858521705A GB8521705A GB8521705D0 GB 8521705 D0 GB8521705 D0 GB 8521705D0 GB 858521705 A GB858521705 A GB 858521705A GB 8521705 A GB8521705 A GB 8521705A GB 8521705 D0 GB8521705 D0 GB 8521705D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858521705A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB858521705A priority Critical patent/GB8521705D0/en
Publication of GB8521705D0 publication Critical patent/GB8521705D0/en
Priority to US06/862,817 priority patent/US4929444A/en
Priority to DE19863617752 priority patent/DE3617752A1/en
Priority to PT82646A priority patent/PT82646B/en
Priority to DK246786A priority patent/DK163173C/en
Priority to IL78938A priority patent/IL78938A/en
Priority to NL8601355A priority patent/NL8601355A/en
Priority to IT48065/86A priority patent/IT1191926B/en
Priority to GB8612780A priority patent/GB2176702B/en
Priority to CH2126/86A priority patent/CH665356A5/en
Priority to HU862234A priority patent/HU195733B/en
Priority to LU86444A priority patent/LU86444A1/en
Priority to CA000510097A priority patent/CA1300008C/en
Priority to FR8607552A priority patent/FR2583984B1/en
Priority to NZ216307A priority patent/NZ216307A/en
Priority to AU57964/86A priority patent/AU567236B2/en
Priority to BE0/216711A priority patent/BE904830A/en
Priority to ES555353A priority patent/ES8800601A1/en
Priority to NO862096A priority patent/NO171345C/en
Priority to SE8602405A priority patent/SE462016B/en
Priority to FI862227A priority patent/FI85335C/en
Priority to GR861366A priority patent/GR861366B/en
Priority to ES557374A priority patent/ES8802439A1/en
Priority to US07/226,422 priority patent/US4968617A/en
Priority to JP5230427A priority patent/JPH0759517B2/en
Pending legal-status Critical Current

Links

GB858521705A 1985-05-28 1985-08-31 Formulation Pending GB8521705D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB858521705A GB8521705D0 (en) 1985-08-31 1985-08-31 Formulation
US06/862,817 US4929444A (en) 1985-05-28 1986-05-13 Low pH pharmaceutical formulation containing t-PA
GR861366A GR861366B (en) 1985-05-28 1986-05-27 Novel formulation
CA000510097A CA1300008C (en) 1985-05-28 1986-05-27 Acid lyophilised pharmaceutical formulation of tissue plasminogen activator
FR8607552A FR2583984B1 (en) 1985-05-28 1986-05-27 LYOPHILIZED PHARMACEUTICAL FORMULATION OF PLASMINOGEN TISSUE ACTIVATOR, PROCESS FOR PREPARING SAME, CONTAINER CONTAINING SAME AND SALT OF PLASMINOGEN TISSUE ACTIVATOR
DK246786A DK163173C (en) 1985-05-28 1986-05-27 PROCEDURE FOR THE PREPARATION OF A LYOPHILIZED PHARMACEUTICAL PREPARATION OF TABLE PLASMINOGEN ACTIVATOR (T-PA)
IL78938A IL78938A (en) 1985-05-28 1986-05-27 Pharmaceutical composition containing lyophilized tissue plasminogen activator and its preparation
NL8601355A NL8601355A (en) 1985-05-28 1986-05-27 NEW COMPOSITION.
IT48065/86A IT1191926B (en) 1985-05-28 1986-05-27 LYOPHILIZED PHARMACEUTICAL FORMULATION OF TISSUE PLASMINOGEN ACTIVATOR AND RELATED PREPARATION PROCEDURE
GB8612780A GB2176702B (en) 1985-05-28 1986-05-27 Novel formulation.
CH2126/86A CH665356A5 (en) 1985-05-28 1986-05-27 PHARMACEUTICAL FORMULATION.
HU862234A HU195733B (en) 1985-05-28 1986-05-27 Process for preparing a pharmaceutical composition containing tissue plasminogen activator
LU86444A LU86444A1 (en) 1985-05-28 1986-05-27 NEW COMPOSITION OF PLASMINOGEN TISSUE ACTIVATOR
DE19863617752 DE3617752A1 (en) 1985-05-28 1986-05-27 TISSUE PLASMINOGEN ACTIVATOR, THE PHARMACEUTICAL FORMULATIONS CONTAINING THEM, THEIR PRODUCTION AND THEIR USE IN HUMAN AND VETERINE MEDICINE
PT82646A PT82646B (en) 1985-05-28 1986-05-27 Process for the preparation of lyophilized pharmaceutical compositions comprising a plasticizer activator of woven fabrics
NZ216307A NZ216307A (en) 1985-05-28 1986-05-27 Pharmaceutical compositions containing tissue plasminogen activator
AU57964/86A AU567236B2 (en) 1985-05-28 1986-05-27 Pharmaceutical formulation of tissue plasminogen activator
BE0/216711A BE904830A (en) 1985-05-28 1986-05-27 NEW COMPOSITION OF PLASMINOGEN TISSUE ACTIVATOR.
ES555353A ES8800601A1 (en) 1985-05-28 1986-05-27 Solid hydrochloride salt of t-PA
NO862096A NO171345C (en) 1985-05-28 1986-05-27 PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING Tissue PLASMINOGEN ACTIVATOR
SE8602405A SE462016B (en) 1985-05-28 1986-05-27 PROCEDURE FOR ORGANIZING A LYOFILIZED PHARMACEUTICAL COMPOSITION WITH TISSUE PLASMINOGEN ACTIVATOR, T-PA
FI862227A FI85335C (en) 1985-05-28 1986-05-27 Process for Preparation of Lyophilized Pharmaceutical Tissue Plasma Minogen Activator (t-PA) Composition
ES557374A ES8802439A1 (en) 1985-05-28 1987-02-10 Solid hydrochloride salt of t-PA
US07/226,422 US4968617A (en) 1985-05-28 1988-07-29 Solid hydrochloride salt of t-PA
JP5230427A JPH0759517B2 (en) 1985-05-28 1993-09-16 Pharmaceutical composition containing tissue plasminogen activator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858521705A GB8521705D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (1)

Publication Number Publication Date
GB8521705D0 true GB8521705D0 (en) 1985-10-02

Family

ID=10584552

Family Applications (1)

Application Number Title Priority Date Filing Date
GB858521705A Pending GB8521705D0 (en) 1985-05-28 1985-08-31 Formulation

Country Status (1)

Country Link
GB (1) GB8521705D0 (en)

Similar Documents

Publication Publication Date Title
GB2176703B (en) Novel formulation
GB8612780D0 (en) Formulation
AR242568A1 (en) Methylenedioxyphenanthrene
GB8513358D0 (en) Formulation
GB8529500D0 (en) Formulation
GB8524812D0 (en) Formulation
GB8521705D0 (en) Formulation
GB8521704D0 (en) Formulation
GB8506703D0 (en) Formulation
GB8500591D0 (en) Formulation
IL93223A0 (en) Formulations comprising 31-azido-31-deoxythymidine
GB8523690D0 (en) Formulations
GB8406326D0 (en) Formulation
GB8425313D0 (en) Formulation
AU91067S (en) Trestle
PL257276A1 (en) Trepanobiopsy set
CS14985A1 (en) Usporadani kontaktovacich ploch v mikrovlnnem spoji
CS723885A1 (en) Zpusob stanoveni koncentrace mikroorganismu v submersnich kultivacich
CS127285A1 (en) Zapojeni automatickeho systemu vyhodnoceni zejmena teploty v dolech
CS122185A1 (en) Sposob znizenia zatazenia velkoplosnych kontaktnych pilierov v okoli vydobyteho priestoru v horskom masive
CS172285A1 (en) Zapojeni bloku tvorby kmitoctu v zapisovaci
CS201885A1 (en) Dvojucelovy nosic injektaznich trysek v prestupnikovem kolenu koksovaci komory
CS214385A1 (en) Ulozeni membrany v elektromigracnim pristroji
CS238885A1 (en) Sposob urcenia najspolahlivejsej prenosovej cesty medzi dvojicou uzlov v telekomunikacnej sieti
CS379785A1 (en) Zpusob mereni vykonu elektromagnetickeho zareni absorbovaneho v ekeltricky ztratovych prostredich